August 02, 2019, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patient...

On June 07,2019,The U.S. Food and Drug Administration today permitted marketing of the first medical device to aid in the reduction of functi...

May 24,2019, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endoc...

On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment o...

By: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research The FDAs Center for Biologics Evaluation and Research (C...

On April 12, 2019,The U.S. Food and Drug Administration granted accelerated approval to Balversa (erdafitinib), a treatment for adult patient...

On Mar 19,2019,the U.S. Food and Drug Administration approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of ...

The U.S. Food and Drug Administration today finalized two guidances to drive the efficient development of a novel technology that scans a per...